期刊文献+

雌激素对去势小鼠LPL、HL活性的影响 被引量:1

Effect of estrogen on the activity of lipoprotein lipase and hepatic lipase in ovariectomized mice
暂未订购
导出
摘要 目的 探讨雌激素对卵巢切除 (OVX)的去势小鼠脂蛋白脂酶 (LPL)和肝脂肪酶 (HL)活性的影响。方法 将 30只成年的雌鼠随机分 3组 ,每组 10只。A组为正常饲料 +OVX +生理盐水 ,B组为高脂饲料 +OVX +生理盐水 ,C组为高脂饲料 +OVX +雌激素。喂养 10周后取血 ,分别检测甘油三酯 (TG)、血清脂蛋白脂肪酶 (LPL)、肝脂肪酶 (HL)水平。结果 A、B和C组的TG分别是 (0 2 7± 0 14 )mmol/L、(0 2 8± 0 10 )mmol/L和 (0 30± 0 14 )mmol/L。A、B和C组的LPL分别是 (1 6 7±0 35 )mmol/L、(1 5 3± 0 32 )mmol/L和 (1 0 0± 0 2 8)mmol/L。A、B和C组的HL分别为 (0 4 5± 0 11)mmol/L、(0 4 3± 0 11)mmol/L和 (0 2 9± 0 13)mmol/L。各组的TG差异无显著性 ,但C组的LPL及HL均比对照组低 (P <0 0 5 )。结论 雌激素能降低去势小鼠LPL、HL活性。 Objective To investigate the effects of estrogen on lipoprotein lipase(LPL) and hepatic lipase(HL) in ovariectomized(OVX) mice.Methods Thirty female mice were randomly divided into three groups, there are 10 in each group. Group A: normal feeding +OVX + normal saline(NS) ; Group B :cholesterol feeding + OVX +NS; Group C : cholesterol feeding + OVX+ estradiol benzoate. After fed for 10 weeks, all mice were sacrified and the activity of LPL or HL and the level of triglyceride(TG) were measured.Results The TG of A,B and C group were (0.27±0.14) mmol/L, (0.28±0.10) mmol/L and (0.30±0.14) mmol/L, respectively. The level of LPL of A,B and C group were (1.67±0.35) mmol/L, (1.53±0.32) mmol/L and (1.00±0.28) mmol/L, respectively. The level of HL of A,B and C group were (0.45±0.11) mmol/L, (0.43±0.11) mmol/L and (0.29±0.13) mmol/L, respectively. The triglyceride level of group C was not statistically higher compared with group B and C. The level of LPL and HL of group C were significantly decreased as compared with group A and B(P<0.05).Conclusion Estrogen could decrease the activity of LPL and HL.
出处 《广西医学》 CAS 2004年第6期787-789,共3页 Guangxi Medical Journal
基金 广西医科大学校长基金资助项目 (2 0 0 2年第 3号 )
关键词 雌激素 小鼠 LPL HL Estrogen Mouse Lipoprotein lipase Hepatic lipase
  • 相关文献

参考文献6

二级参考文献26

  • 1林蓓,李春桃,陈桂兰,魏军,刘伟,郭津津,王富伟,王继东,崔波.妊高征患者血清载脂蛋白及脂蛋白(a)含量的测定[J].中华妇产科杂志,1995,30(7):417-418. 被引量:16
  • 2武须军,尹永洗.脂蛋白(a)研究概况[J].国外医学(临床生物化学与检验学分册),1989,10(3):16-19. 被引量:2
  • 3[1]Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med, 1991,325:1196-1204
  • 4[2]Skafar DF, Xu R, Morales J, et al. Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab, 1997, 82:3913-3918
  • 5[3]Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med, 2000, 343:522-529
  • 6[4]Hemminki E, McPherson K. Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease. Lancet, 2000, 355:566-569
  • 7[5]Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA, 1998,208:605-613
  • 8[6]Furberg CD, Vittinghoff E, Davidson M, et al. Subgroup interactions in the Heart and Estrogen/progestin Replacement Study. Circulation, 2002, 105:917-922
  • 9[7]Heckbert SR, Weiss NS, Psaty BM. Hormone replacement therapy for secondary prevention of coronary heart disease [letter] . JAMA, 1999, 281:795-796
  • 10[8]Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study. A prospective, observational study. Ann Intern Med, 2001, 135:1-8

共引文献42

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部